The Tumor Microenvironment

2010
ISBN: 978-1-4419-6614-8
Verlag: Springer

Buch, Englisch, 770 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 1475 g

Reihe: Cancer Drug Discovery and Development

The fact that tumors are composed of both tumor cells and host cells has long been known. These tumor-associated cells include vascular endothelial cells and pe- cytes, as well as inflammatory cells such as neutrophils, monocytes, macrophages, mast cells and eosinophils, and lymphocytes. The tumor cells also interact with stromal cells and with elements of the tissue extracellular matrix. What has been less appreciated is the role that these cells could have in modulating the growth, invasion, and metastasis of the tumor. Early on, the elements of what we now call the tumor microenvironment were considered to be more or less innocent bysta- ers to the role of the tumor cells as they grew and invaded local sites. Today, there is an increased understanding of the critical role of the tumor microenvironment as dramatically influencing the course of tumor development and dissemination. This volume represents a superb compilation of the latest thoughts and data regarding the role of each essential component of the tumor microenvironment in cancer development and progression. Perhaps, the earliest recognition of the role of nonmalignant cells as cancer re- lators was the recognition that lymphocytes can participate in what was termed “immune surveillance” in the 1960s. Our understanding of tumor immunity has improved markedly since then, and there are now successful clinical studies sh- ing the potential use of immune-based therapies in cancer treatment.

Zielgruppe

Research

Autoren/Hrsg.

Bagley, Rebecca G.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

Physiological Parameters.- Combination Strategies Targeting Hypoxia Inducible Factor 1 (HIF-1) for Cancer Therapy.- The Tumor Microenvironment: New Insights into Regulation of Tumor pH by Carbonic Anhydrases.- Hypoxia, Gene Expression, and Metastasis.- Molecular Mechanisms Regulating Expression and Function of Cancer-Associated Carbonic Anhydrase IX.- Glycolytic Pathway as a Target for Tumor Inhibition.- Malignant Cells.- Aberrant DNA Methylation in Cancer Cells.- DNA Repair and Redox Signaling.- Cancer Stem Cells and Microenvironment.- Epithelial–Mesenchymal Transition in Development and Diseases.- Invasion and Metastasis.- Dormancy of Disseminated Tumor Cells: Reciprocal Crosstalk with the Microenvironment.- Vasculature And Stroma.- Impact of Endothelial Progenitor Cells on Tumor Angiogenesis and Outcome of Antiangiogenic Therapy: New Perspectives on an Ongoing Controversy.- Bone Marrow Derived Mesenchymal Stem/Stromal Cells and Tumor Growth.- Integrin Signaling in Lymphangiogenesis.- Role of Pericytes in Resistance to Antiangiogenic Therapy.- Tumour-Promoting Stromal Myofibroblasts in Human Carcinomas.- Immune-Mediated Cells.- Mast Cells and Tumor Microenvironment.- Macrophages in the Tumor Microenvironment.- The Prognostic Significance of Tumor-Infiltrating Lymphocytes.- The Pro-inflammatory Milieu and Its Role in Malignant Epithelial Initiation.- Natural Killer Cells for Adoptive Immunotherapy.- Extracellular Matrix.- Fibronectin.- Collagen in Cancer.- Integrins and Cancer.- Matrix Metalloproteinases and Cancer Cell Invasion/Metastasis.- Tetraspanins and Cancer Metastasis.- Secreted Proteins.- Chemokines and Metastasis.- Transforming Growth Factor-? in Lung Cancer, Carcinogenesis, and Metastasis.- Cooperative Interactions Between Integrins and Growth FactorSignaling in Pathological Angiogenesis.- The Extracellular Matrix and the Growth and Survival of Tumors.- Secreted Growth Factors as Therapeutic Targets.- Adrenomedullin.

Über Autor(innen)

Rebecca Bagley is a senior scientist at Genzyme Corporation and has worked in the biotechnology industry for 20 years with degrees in biology from Wellesley College and Harvard University. Her expertise in drug development spans a wide range of approaches including immunotherapies, gene and protein therapies, and small molecule delivery with publications in journals such as Molecular Cancer Therapeutics, Cancer Research, and Microvascular Research. Her current research focuses on stem cells, tumor vasculature, and target validation.